Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx Group (MDXG) Shares Outstanding (Weighted Average): 2011-2025

Historic Shares Outstanding (Weighted Average) for Mimedx Group (MDXG) over the last 15 years, with Sep 2025 value amounting to $148.0 million.

  • Mimedx Group's Shares Outstanding (Weighted Average) rose 0.78% to $148.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $148.0 million, marking a year-over-year increase of 0.78%. This contributed to the annual value of $146.9 million for FY2024, which is 0.01% down from last year.
  • Mimedx Group's Shares Outstanding (Weighted Average) amounted to $148.0 million in Q3 2025, which was up 0.17% from $147.7 million recorded in Q2 2025.
  • In the past 5 years, Mimedx Group's Shares Outstanding (Weighted Average) registered a high of $148.0 million during Q3 2025, and its lowest value of $111.3 million during Q1 2021.
  • Moreover, its 3-year median value for Shares Outstanding (Weighted Average) was $147.0 million (2024), whereas its average is $138.6 million.
  • In the last 5 years, Mimedx Group's Shares Outstanding (Weighted Average) climbed by 29.29% in 2023 and then dropped by 0.01% in 2024.
  • Mimedx Group's Shares Outstanding (Weighted Average) (Quarterly) stood at $112.1 million in 2021, then grew by 1.36% to $113.7 million in 2022, then climbed by 29.29% to $147.0 million in 2023, then decreased by 0.01% to $146.9 million in 2024, then climbed by 0.78% to $148.0 million in 2025.
  • Its last three reported values are $148.0 million in Q3 2025, $147.7 million for Q2 2025, and $147.4 million during Q1 2025.